Keywords: Body, Pediatric, liver, pancreas, spleen
Motivation: Cystic fibrosis (CF) is a multi-system, life-limiting genetic disorder. There is a need for multiorgan assessment in children with CF and the response to modulator therapies.
Goal(s): To perform multiorgan MRI in children to quantify lung, liver, pancreas, spleen, and gut function.
Approach: 8 children with CF and 3 healthy volunteers (HV) performed the protocol including quantitative assessment (T1, T2, T2*, fat fraction (FF), stiffness) of liver, pancreas and spleen.
Results: Increased pancreas FF, T1 and T2, spleen T1 and hepatic arterial velocity in CF compared to HVs. Increased liver T1, T2 and stiffness in a CF child independently diagnosed with liver disease.
Impact: This protocol will be used to study the effect of the Cystic Fibrosis Transmembrane Regulator Modulator therapy in children on liver toxicity, pancreas and gut function, and lung health, by performing MRI before and 12 months after commencement of Kaftrio.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords